Have a personal or library account? Click to login
Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis Cover

Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis

Pneumologia
Volume 70 (2021): Issue 3 (October 2021)
By: Ionela-Alina Grosu-Creangă,  Antigona Carmen Trofor,  Radu Adrian Crișan-Dabija,  Daniela Robu-Popa,  Cristina Mihaela Ghiciuc and  Elena Cătălina Lupușoru  
Open Access
|Oct 2022

Authors

Ionela-Alina Grosu-Creangă

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
Clinical Hospital of Pulmonary Diseases, Iaşi, Romania

Antigona Carmen Trofor

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
Clinical Hospital of Pulmonary Diseases, Iaşi, Romania

Radu Adrian Crișan-Dabija

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
Clinical Hospital of Pulmonary Diseases, Iaşi, Romania

Daniela Robu-Popa

rb_dana@yahoo.com

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
Clinical Hospital of Pulmonary Diseases, Iaşi, Romania

Cristina Mihaela Ghiciuc

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
Department of Morpho-Functional Sciences II – Pharmacology and Clinical Pharmacology, at “Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania

Elena Cătălina Lupușoru

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
Department of Morpho-Functional Sciences II – Pharmacology and Clinical Pharmacology, at “Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania
DOI: https://doi.org/10.2478/pneum-2022-0029 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Journal RSS Feed
Language: English
Page range: 117 - 126
Published on: Oct 21, 2022
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
DR-TB,
second-line drugs,
adverse drug effects
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Pneumology,
Clinical medicine, other

© 2022 Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc, Elena Cătălina Lupușoru, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 70 (2021): Issue 3 (October 2021)Next article